The project finances the construction and operation of a Large Volume Parenteral healthcare product manufacturing plant in Indonesia.
The project consists of an A-loan to two Indonesian subsidiaries of B.Braun Melsungen AG, one of the world´s leading manufacturer and supplier of healthcare products. B.Braun Melsungen AG is a large private family-owned company created in 1839 by Julius Wilhelm Braun in Melsungen, Germany and which employs more than 54,000 people with an international presence in more than 60 countries. PT B.Braun Indonesia is fully owned by the Group while the second co-borrower, PT B.Braun Pharmaceutical Indonesia is owned at 85% by the Group and 15% by a local shareholder.
Mr Eko Peryatno
General Manager – Plant
Palma One Building, 14th Floor Suite 1401
Jl. HR Rasuna Said Kav, X-2 No. 4
Jakarta 12950, Indonesia
Tel: +62 21 5290 7177
ACCOUNTABILITY MECHANISM OF IFC
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org. You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org/